James P. Chandler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James P. Chandler has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Joseph G. Adel
Northwestern University, McGaw Medical Center
3 shared publications- Jeffrey J. Raizer
Northwestern University
2 shared publications - John A. Kalapurakal
Department of Radiation Oncology, Northwestern University, Chicago, IL, USA
2 shared publications Maryanne H. Marymont
Department of Radiation Oncology, Northwestern University McGaw Medical Center, Chicago, IL, USA
2 shared publications- Minesh P. Mehta
Miami Cancer Institute, Baptist Health South Florida, Miami, FL
2 shared publications - Qinwen Mao
Mesulam Institute for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University Chicago Illinois USA
2 shared publications
Latest Publications
- 1 July 2018
- Published by Elsevier in World Neurosurgery
- Vol. 115, e13-e21
Surgical Resection and Adjuvant Radiation Therapy in the Treatment of Skull Base Chordomas
- 1 July 2018
- Published by Elsevier in World Neurosurgery
- Vol. 115, e13-e21
Surgical Resection and Adjuvant Radiation Therapy in the Treatment of Skull Base Chordomas
- 1 February 2018
- Published by Elsevier in World Neurosurgery
- Vol. 110, e231-e238
Endoscopic Approach to Clival Chordomas: The Northwestern Experience
- 1 February 2018
- Published by Elsevier in World Neurosurgery
- Vol. 110, e231-e238
Endoscopic Approach to Clival Chordomas: The Northwestern Experience
- 26 July 2014
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 120 (2) , 347-352
Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period
Patients with high-grade glioma are at elevated risk of venous thromboembolism (VTE). The relationship between VTE and survival in glioma patients remains unclear, as does the optimal protocol for chemoprophylaxis. The purpose of this study was to assessthe incidence of and risk factors associated with VTE in patients with high-grade glioma, and the correlation between VTE and survival in this population. Furthermore, we sought to define a protocol for perioperative DVT prophylaxis. This was a retrospective review of patients who underwent craniotomy for resection of high-grade glioma (WHO grade III or IV) at Northwestern University between 1999 and 2010. A total of 336 patients met inclusion criteria. 53 patients developed postoperative VTE (15.7 %). Median survival was 12.0 months and was not significantly different between VTE(+) and VTE(−) patients. Demographics and surgical factors were not significantly correlated with VTE development. Prior history of VTE was highly predictive of postoperative VTE (OR 7.1, p < .01), as was seizure (OR 2.4, p = .005). Increased duration of postoperative ICU stay was also a risk factor for VTE (p = .025). 25 patients in our study received prophylactic anticoagulation(pAC) with either heparin or enoxaparin. Early initiation of pAC was associated with decreased incidence of VTE (p = .042). There were no hemorrhagic complications in patients receiving pAC. VTE is a common complication in high-grade glioma patients. Early initiation of anticoagulation is safe and may decrease the risk of VTE. We recommend initiation of chemoprophylaxis on postoperative day 1 in patients without contraindication.
- 26 July 2014
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 120 (2) , 347-352
Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period
Patients with high-grade glioma are at elevated risk of venous thromboembolism (VTE). The relationship between VTE and survival in glioma patients remains unclear, as does the optimal protocol for chemoprophylaxis. The purpose of this study was to assessthe incidence of and risk factors associated with VTE in patients with high-grade glioma, and the correlation between VTE and survival in this population. Furthermore, we sought to define a protocol for perioperative DVT prophylaxis. This was a retrospective review of patients who underwent craniotomy for resection of high-grade glioma (WHO grade III or IV) at Northwestern University between 1999 and 2010. A total of 336 patients met inclusion criteria. 53 patients developed postoperative VTE (15.7 %). Median survival was 12.0 months and was not significantly different between VTE(+) and VTE(−) patients. Demographics and surgical factors were not significantly correlated with VTE development. Prior history of VTE was highly predictive of postoperative VTE (OR 7.1, p < .01), as was seizure (OR 2.4, p = .005). Increased duration of postoperative ICU stay was also a risk factor for VTE (p = .025). 25 patients in our study received prophylactic anticoagulation(pAC) with either heparin or enoxaparin. Early initiation of pAC was associated with decreased incidence of VTE (p = .042). There were no hemorrhagic complications in patients receiving pAC. VTE is a common complication in high-grade glioma patients. Early initiation of anticoagulation is safe and may decrease the risk of VTE. We recommend initiation of chemoprophylaxis on postoperative day 1 in patients without contraindication.
- 1 July 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (7) , 1225-1228
Delayed malignant transformation of petroclival meningioma to chondrosarcoma after stereotactic radiosurgery
- 1 July 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (7) , 1225-1228
Delayed malignant transformation of petroclival meningioma to chondrosarcoma after stereotactic radiosurgery
- 1 December 2013
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 20 (12) , 1795-1797
Brain tumors and the area postrema
- 1 December 2013
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 20 (12) , 1795-1797
Brain tumors and the area postrema
- Open Access
- 1 January 2013
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 4 (1) , 59
Orbital metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze palsy
Although pituitary adenoma is one of the most common intracranial tumors, it rarely progresses secondarily into a metastatic carcinoma. Commonalities in reported cases include subtotal resection at presentation, treatment with radiation therapy, and delayed metastatic progression. Pathologic descriptions of these lesions are varying and inconsistent. A 52-year-old male was diagnosed with acromegaly and pituitary tumor in 1996. He underwent four subtotal resections and five courses of stereotactic radiosurgery over 14 years. He developed left eye lateral gaze palsy, and was found to have a distant orbital metastasis with involvement of the left lateral rectus and lateral orbital wall. He underwent left orbital craniotomy via eyebrow incision for resection of this lesion. Pathologic evaluation showed a markedly elevated Ki67 level of 30%. While overall incidence of metastatic progression of pituitary adenoma after radiotherapy appears to be low, it appears to be a possible complication, and could be more likely in patients receiving multiple doses of radiotherapy. Our review of reported cases showed that 45/46 (97.8%) of patients developing carcinoma had prior radiation exposure. These patients may also have more aggressive pathologic characteristics of their lesions.
- 1 January 2013
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 4 (1) , 59
Open AccessOrbital metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze palsy
Although pituitary adenoma is one of the most common intracranial tumors, it rarely progresses secondarily into a metastatic carcinoma. Commonalities in reported cases include subtotal resection at presentation, treatment with radiation therapy, and delayed metastatic progression. Pathologic descriptions of these lesions are varying and inconsistent. A 52-year-old male was diagnosed with acromegaly and pituitary tumor in 1996. He underwent four subtotal resections and five courses of stereotactic radiosurgery over 14 years. He developed left eye lateral gaze palsy, and was found to have a distant orbital metastasis with involvement of the left lateral rectus and lateral orbital wall. He underwent left orbital craniotomy via eyebrow incision for resection of this lesion. Pathologic evaluation showed a markedly elevated Ki67 level of 30%. While overall incidence of metastatic progression of pituitary adenoma after radiotherapy appears to be low, it appears to be a possible complication, and could be more likely in patients receiving multiple doses of radiotherapy. Our review of reported cases showed that 45/46 (97.8%) of patients developing carcinoma had prior radiation exposure. These patients may also have more aggressive pathologic characteristics of their lesions.
- 30 September 2012
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 215 (3) , S65
The goal of this study is to analyze risk factors for venous thromboembolism (VTE) development in high grade glioma patients undergoing surgery, and to assess the impact of deep venous thrombosis (DVT) development on survival after surgery
- 30 September 2012
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 215 (3) , S65
The goal of this study is to analyze risk factors for venous thromboembolism (VTE) development in high grade glioma patients undergoing surgery, and to assess the impact of deep venous thrombosis (DVT) development on survival after surgery
- 30 September 2012
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 215 (3) , S65
Retrospective review of thromboembolic phenomena following craniotomy for brain tumor
- 30 September 2012
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 215 (3) , S65
Retrospective review of thromboembolic phenomena following craniotomy for brain tumor
- 18 March 2012
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 108 (1) , 141-146
Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases
The objective of this study is to evaluate the patterns of relapse and survival trends in patients with single brain metastases treated with post-operative adjuvant Gamma knife stereotactic radiosurgery (GKS) without whole brain radiotherapy (WBRT). Retrospective analysis of all consecutive patients who underwent GKS to the tumor cavity following resection of solitary brain metastasis was performed at a single institution. Between March 2001 and June 2010, 56 patients underwent GKS to the resection cavity following resection of intracranial metastases; no patient received pre- or post-operative WBRT as an adjuvant (salvage WBRT was permissible). The mean marginal dose was 17.1 Gy (range 14–20 Gy). The mean follow-up period was 24 months (range 3–99 months). Five patients (8.9%) had local recurrence in the immediate vicinity of the resection cavity, qualifying as “local failures”, and 21 (37.5%) recurred at distant intracranial sites. Median intracranial recurrence free survival was 13 months. Median overall survival was 20.5 months. Salvage interventions were required in 26 patients, and included repeat radiosurgery in 17 patients, further surgery in two patients, and salvage WBRT in eight (14.3%; two of whom had also been locally salvaged with repeat radiosurgery) patients. As expected, avoidance of WBRT results in a high rate of intracranial failure (26/56 patients, 46%), even in well-selected patients with only single brain metastases. As anticipated, the majority of failures (21, 37.5%) are “distant intracranial”, and in this well-selected cohort the local failure rate is low (5/56 patients, <9%). All patients failing intracranially (46%) are potential candidates for salvage therapies, but WBRT as salvage was utilized in only 14.3% of patients. The median intracranial relapse-free was 13 months and overall survival was 20.5 months.
- 18 March 2012
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 108 (1) , 141-146
Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases
The objective of this study is to evaluate the patterns of relapse and survival trends in patients with single brain metastases treated with post-operative adjuvant Gamma knife stereotactic radiosurgery (GKS) without whole brain radiotherapy (WBRT). Retrospective analysis of all consecutive patients who underwent GKS to the tumor cavity following resection of solitary brain metastasis was performed at a single institution. Between March 2001 and June 2010, 56 patients underwent GKS to the resection cavity following resection of intracranial metastases; no patient received pre- or post-operative WBRT as an adjuvant (salvage WBRT was permissible). The mean marginal dose was 17.1 Gy (range 14–20 Gy). The mean follow-up period was 24 months (range 3–99 months). Five patients (8.9%) had local recurrence in the immediate vicinity of the resection cavity, qualifying as “local failures”, and 21 (37.5%) recurred at distant intracranial sites. Median intracranial recurrence free survival was 13 months. Median overall survival was 20.5 months. Salvage interventions were required in 26 patients, and included repeat radiosurgery in 17 patients, further surgery in two patients, and salvage WBRT in eight (14.3%; two of whom had also been locally salvaged with repeat radiosurgery) patients. As expected, avoidance of WBRT results in a high rate of intracranial failure (26/56 patients, 46%), even in well-selected patients with only single brain metastases. As anticipated, the majority of failures (21, 37.5%) are “distant intracranial”, and in this well-selected cohort the local failure rate is low (5/56 patients, <9%). All patients failing intracranially (46%) are potential candidates for salvage therapies, but WBRT as salvage was utilized in only 14.3% of patients. The median intracranial relapse-free was 13 months and overall survival was 20.5 months.